GLP-1 Market
LLY $1149.85 ▼ -0.6% NVO $37.40 ▼ -1.3% PFE $28.12 ▼ -1.4% VKTX $30.51 ▼ -6.4% KLRA $11.03 ▼ -3.4% GPCR $28.98 ▼ -7.3% RHHBY $52.35 ▲ +0.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Fluorouracil

Company
National Cancer Institute (NCI)
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
74 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

74 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 2, 2026

Find a Clinical Trial Near Me

See recruiting studies for Fluorouracil and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04120701

    CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

    Not yet reported Centre Hospitalier Universitaire Dijon 1980 participants Est. completion 2032-03 1 site
    Other conditions: Patients With Resected Stage II Colon Cancer
    View official trial listing →
  • Recruiting NCT NCT04150640

    Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

    Not yet reported University of Wisconsin, Madison 52 participants Est. completion 2028-05 1 site
    Other conditions: Esophageal Adenocarcinoma, Gastric Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT04516681

    Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

    Not yet reported Fudan University 400 participants Est. completion 2025-12-01 1 site
    Other conditions: Colorectal Cancer, Vitamin C, GLUT3
    View official trial listing →
  • Recruiting NCT NCT04847063

    Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

    Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2034-12-30 1 site Stand-alone
    Other conditions: Peritoneal Mesothelioma, Peritoneal Carcinomatosis, Ovarian Cancer, Gastrointestinal Cancer, Appendiceal Cancer, Atypical Mesothelial Proliferation, Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT04894370

    Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma

    Not yet reported Centre Hospitalier Universitaire de Besancon 34 participants Est. completion 2026-11-01 5 sites
    Other conditions: Squamous Cell Anal Carcinoma, Metastatic Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT04920032

    Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

    Not yet reported University of California, Irvine 22 participants Est. completion 2028-01-21 1 site
    Other conditions: Colon Adenocarcinoma, Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT04926467

    Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

    Not yet reported Baylor Research Institute 24 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT04991948

    Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

    Not yet reported Celyad Oncology SA 34 participants Est. completion 2038-05-25 5 sites
    Other conditions: Unresectable Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT05044117

    Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)

    Not yet reported Sun Yat-sen University 220 participants Est. completion 2026-10 1 site
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05381597

    5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer

    Not yet reported, Not yet reported Boston University 200 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ
    View official trial listing →
  • Recruiting NCT NCT05424692

    Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2027-09-01 1 site Stand-alone
    Other conditions: Colon Cancer, Rectal Cancer, Chemotherapy Effect, PTC, Exon Mutation
    View official trial listing →
  • Recruiting NCT NCT05476432

    HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

    Not yet reported Sun Yat-sen University 300 participants Est. completion 2026-10-01 3 sites Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05514275

    Radiotherapy Combined With Endostatin and Capecitabine for NPC

    Not yet reported Zhejiang Cancer Hospital 41 participants Est. completion 2028-08-01 7 sites
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05624138

    The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

    Not yet reported Tanta University 64 participants Est. completion 2025-06 1 site
    Other conditions: Neuropathy;Peripheral
    View official trial listing →
  • Recruiting NCT NCT05719558

    A Study of ASP1002 in Adults for Treatment of Solid Tumors

    Not yet reported Astellas Pharma Global Development, Inc. 798 participants Est. completion 2030-05-31 15 sites Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05859750

    A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

    Not yet reported Akeso 78 participants Est. completion 2025-12 7 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05972655

    Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

    Not yet reported Sir Run Run Shaw Hospital 32 participants Est. completion 2026-05-01 1 site
    Other conditions: Low Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06006650

    Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell

    Not yet reported Tang-Du Hospital 114 participants Est. completion 2031-12-31 3 sites Stand-alone
    Other conditions: Neoadjuvent, PD-1 Inhibitor, Chemotherapy, Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06016387

    Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study

    Not yet reported Sunnybrook Health Sciences Centre 30 participants Est. completion 2028-10-05 2 sites
    Other conditions: HER2-positive Breast Cancer, LMD
    View official trial listing →
  • Recruiting NCT NCT06048484

    Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

    Not yet reported Gulam Manji 60 participants Est. completion 2027-04 5 sites Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06054906

    Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer

    Not yet reported Huashan Hospital 50 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06090994

    Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

    Not yet reported Fudan University 756 participants Est. completion 2029-11 9 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06154538

    Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 170 participants Est. completion 2028-11-01 3 sites
    Other conditions: Locally Advanced Colorectal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06176534

    Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

    Not yet reported Henan Cancer Hospital 240 participants Est. completion 2026-12-20 1 site
    Other conditions: Advanced Breast Cancer, Treatment, HR Low/HER2 Negative
    View official trial listing →
  • Recruiting NCT NCT06225843

    Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis

    Not yet reported Alethia Biotherapeutics 17 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06244225

    HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 38 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06278545

    Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma

    Not yet reported Centre Hospitalier Universitaire Dijon 130 participants Est. completion 2029-02 1 site
    Other conditions: Locally Advanced or Metastatic Small Bowel Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06339619

    Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 32 participants Est. completion 2028-09-01 1 site
    Other conditions: Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06363825

    A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

    Not yet reported Fujian Medical University 57 participants Est. completion 2027-05-11 1 site Stand-alone
    Other conditions: Advanced Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06364384

    Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 20 participants Est. completion 2029-06-08 1 site
    Other conditions: Rectal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06393374

    Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

    Not yet reported Merck Sharp & Dohme LLC 1530 participants Est. completion 2037-12-14 311 sites
    Other conditions: Triple-Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06402708

    Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

    Not yet reported Fudan University 172 participants Est. completion 2030-05-01 1 site
    Other conditions: Thymic Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06499415

    Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

    Not yet reported Maastricht University Medical Center 232 participants Est. completion 2029-03-02 4 sites
    Other conditions: Actinic Keratoses
    View official trial listing →
  • Recruiting NCT NCT06519578

    Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

    Not yet reported RenJi Hospital 1115 participants Est. completion 2027-07-31 2 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06531434

    Establishing Best Treatment Strategy for T4 Esophageal Cancer

    Not yet reported, Not yet reported National Cheng-Kung University Hospital 22 participants Est. completion 2026-04-30 1 site Stand-alone
    Other conditions: Esophageal Cancer TNM Staging Primary Tumor (T) T4
    View official trial listing →
  • Recruiting NCT NCT06540326

    Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2027-10-31 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT06598007

    A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Crossignal Therapeutics, Inc. 78 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06764940

    A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

    Not yet reported Biostar Pharma, Inc. 120 participants Est. completion 2027-07-15 12 sites
    Other conditions: HER2-negative Breast Cancer Patients With Brain Metastases
    View official trial listing →
  • Recruiting NCT NCT06793917

    Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

    Not yet reported Fujian Cancer Hospital 269 participants Est. completion 2029-04-01 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06797635

    Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

    Not yet reported Merck Sharp & Dohme LLC 372 participants Est. completion 2034-12-31 17 sites
    Other conditions: Breast Neoplasms, Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06820463

    A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    Not yet reported AbbVie 390 participants Est. completion 2028-04 75 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06835569

    A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    Not yet reported Alterome Therapeutics, Inc. 448 participants Est. completion 2029-08 12 sites Stand-alone
    Other conditions: Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC (Non-small Cell Lung Cancer), CRC (Colorectal Cancer), Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06856447

    The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

    Not yet reported toqa saad mohammed mohammed 22 participants Est. completion 2026-01-10 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06881537

    CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer

    Not yet reported Shanghai Changzheng Hospital 15 participants Est. completion 2028-06-30 1 site
    Other conditions: Locally Recurrent Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06896188

    9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

    Not yet reported Anwaar Saeed 12 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06951503

    AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

    Not yet reported Akeso 560 participants Est. completion 2029-01-07 2 sites
    Other conditions: Colorectal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06966700

    A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    Not yet reported Merck Sharp & Dohme LLC 2400 participants Est. completion 2034-12-29 325 sites
    Other conditions: Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06992336

    Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 411 participants Est. completion 2036-01-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07034742

    Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 136 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Gastric Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07047560

    Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 46 participants Est. completion 2027-08-01 1 site Stand-alone
    Other conditions: Colorectal Cancer (CRC)
    View official trial listing →
  • Recruiting NCT NCT07059299

    A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

    Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 18 participants Est. completion 2027-08 4 sites Stand-alone
    Other conditions: Esophagogastric Junction Adenocarcinoma, Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Resectable Esophagogastric Adenocarcinoma, Neoadjuvant Therapy
    View official trial listing →
  • Recruiting NCT NCT07069712

    A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

    Not yet reported AstraZeneca 100 participants Est. completion 2029-07-16 70 sites Stand-alone
    Other conditions: Gastroesophageal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07070076

    A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

    Not yet reported Li Qiang 286 participants Est. completion 2031-08-01 1 site
    Other conditions: Hepatocellular Carcinoma (HCC)
    View official trial listing →
  • Recruiting NCT NCT07071337

    A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy

    Not yet reported Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430 participants Est. completion 2031-02 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07112053

    A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

    Not yet reported University of Washington 40 participants Est. completion 2028-12-31 1 site
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07267806

    Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC

    Not yet reported Linhui Peng 326 participants Est. completion 2032-10 1 site Stand-alone
    Other conditions: Hepato Cellular Carcinoma (HCC), Chemotherapy Effect
    View official trial listing →
  • Recruiting NCT NCT07277270

    A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

    Not yet reported GlaxoSmithKline 83 participants Est. completion 2030-05-01 22 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07283367

    A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.

    Not yet reported, Not yet reported Hansoh BioMedical R&D Company 502 participants Est. completion 2029-12-31 1 site
    Other conditions: CRC
    View official trial listing →
  • Recruiting NCT NCT07328087

    COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

    Not yet reported Biogenea Pharmaceuticals Ltd. 12 participants Est. completion 2031-12-02 1 site
    Other conditions: Colorectal Cancer Metastatic, Colorectal Cancer Stage III, Colorectal Cancer Stage IV
    View official trial listing →
  • Recruiting NCT NCT07337460

    Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

    Not yet reported Northern Jiangsu People's Hospital 30 participants Est. completion 2028-01-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma (HCC)
    View official trial listing →
  • Recruiting NCT NCT07365592

    Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC

    Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 138 participants Est. completion 2029-12-31 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07384234

    SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis

    Not yet reported Ruijin Hospital 60 participants Est. completion 2030-12-30 2 sites
    Other conditions: Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07392320

    A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

    Not yet reported Sun Yat-sen University 142 participants Est. completion 2033-02-10 1 site
    Other conditions: Nasopharangeal Cancer
    View official trial listing →
  • Recruiting NCT NCT07456852

    Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

    Not yet reported, Not yet reported Mayo Clinic 60 participants Est. completion 2030-04-30 1 site Stand-alone
    Other conditions: Malignant Digestive System Neoplasm
    View official trial listing →
  • Recruiting NCT NCT07468630

    Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma

    Not yet reported Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 106 participants Est. completion 2028-12-31 1 site
    Other conditions: Colon Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07474727

    A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

    Not yet reported Multitude Therapeutics Inc. 180 participants Est. completion 2028-02-28 19 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07543744

    A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

    Not yet reported R-Pharm 180 participants Est. completion 2028-08 26 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07566156

    Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

    Not yet reported Astellas Pharma Global Development, Inc. 390 participants Est. completion 2032-02-29 19 sites
    Other conditions: Urothelial Cancer, Urinary Bladder Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07669298

    Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer

    Not yet reported Medical University of Gdansk 480 participants Est. completion 2037-06 3 sites
    Other conditions: Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07673887

    A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

    Not yet reported Astellas Pharma Global Development, Inc. 570 participants Est. completion 2031-02-28 3 sites Stand-alone
    Other conditions: Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07700667

    SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma

    Not yet reported Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120 participants Est. completion 2029-12-31 24 sites
    Other conditions: Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07736495

    Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis

    Not yet reported, Not yet reported Ain Shams University 50 participants Est. completion 2026-12-29 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07790510

    HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Haisco Pharmaceutical Group Co., Ltd. 180 participants Est. completion 2030-09-30 1 site
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Recruiting NCT NCT07809893

    Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients

    Not yet reported Sun Yat-sen University 45 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00001239

    Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 100 participants Est. completion 2001-01 1 site
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00002498

    Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer

    Not yet reported Leiden University Medical Center 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00002525

    Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

    Not yet reported ECOG-ACRIN Cancer Research Group 859 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00002747

    Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer

    Not yet reported European Institute of Oncology 240 participants 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00002784

    High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 344 participants Est. completion 2011-12 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004142

    Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

    Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2003-12-09 1 site Stand-alone
    Other conditions: Colorectal Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT00004860

    Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

    Not yet reported Eastern Cooperative Oncology Group 51 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00004885

    Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 430 participants 57 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00005036

    Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) 560 participants 1 site Stand-alone
    Other conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00005870

    Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

    Not yet reported Astex Pharmaceuticals, Inc. 2 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT00005944

    Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer

    Not yet reported UNICANCER Est. completion 2003-10-01 18 sites
    Other conditions: Colorectal Cancer, Metastatic Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00006051

    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

    Not yet reported UNICANCER Est. completion 2005-09 6 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00015886

    Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

    Not yet reported Wake Forest University Health Sciences 25 participants Est. completion 2009-07 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00016133

    Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

    Not yet reported, Not yet reported Intracel Est. completion 2004-08 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00025142

    Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

    Not yet reported Stanford University Est. completion 2006-11 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00030342

    Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

    Not yet reported, Not yet reported St. Luke's Medical Center 60 participants Est. completion 2008-01 1 site
    Other conditions: Colorectal Cancer, Kidney Cancer
    View official trial listing →
  • Terminated NCT NCT00036517

    Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

    Not yet reported, Not yet reported PhytoCeutica 30 participants Est. completion 2003-03 3 sites
    Other conditions: Colorectal Neoplasms, Diarrhea
    View official trial listing →
  • Completed NCT NCT00039611

    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) Est. completion 2007-10 19 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00044785

    Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors

    Not yet reported Wellstat Therapeutics 24 participants Est. completion 2004-03 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00047099

    Combination Chemotherapy in Treating Women With Breast Cancer

    Not yet reported Ludwig-Maximilians - University of Munich 446 participants Est. completion 2012-03 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00049244

    BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer

    Not yet reported R-Pharm 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00053807

    Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 96 participants 17 sites
    Other conditions: Kidney Cancer
    View official trial listing →
  • Terminated NCT NCT00053911

    Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer

    Not yet reported UNICANCER 26 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00054457

    Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

    Not yet reported Alliance for Clinical Trials in Oncology 46 participants Est. completion 2008-02 28 sites
    Other conditions: Esophageal Cancer, Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00055601

    Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer

    Not yet reported Radiation Therapy Oncology Group 97 participants Est. completion 2018-05-14 2 sites Stand-alone
    Other conditions: Bladder Cancer
    View official trial listing →
  • Completed NCT NCT00057785

    Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer

    Not yet reported Radiation Therapy Oncology Group 68 participants Est. completion 2016-12 17 sites Stand-alone
    Other conditions: Head and Neck Cancer, Oral Complications of Radiation Therapy, Radiation Toxicity
    View official trial listing →
  • Completed NCT NCT00061815

    Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

    Not yet reported Eli Lilly and Company 102 participants Est. completion 2005-11 39 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00066274

    Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported UNICANCER Est. completion 2007-04-01 17 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00070252

    Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 53 participants Est. completion 2010-06 7 sites
    Other conditions: Adult Solid Neoplasm, Inflammatory Breast Carcinoma, Male Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00075595

    Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 15 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00077077

    DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

    Not yet reported Daiichi Sankyo Est. completion 2006-01 3 sites
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00077233

    FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum

    Not yet reported Alliance for Clinical Trials in Oncology 238 participants Est. completion 2010-06 77 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00077363

    Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 70 participants 1 site
    Other conditions: Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00081536

    Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

    Not yet reported, Not yet reported Aronex Pharmaceuticals 105 participants
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00084591

    Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer

    Not yet reported Fox Chase Cancer Center Est. completion 2007-02 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00093665

    Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer

    Not yet reported Aichi Cancer Center 90 participants 7 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00107276

    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer

    Not yet reported SWOG Cancer Research Network 112 participants Est. completion 2009-08 145 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00119314

    Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

    Not yet reported University of Medicine and Dentistry of New Jersey Est. completion 2005-07 6 sites
    Other conditions: Carcinoma of Unknown Primary
    View official trial listing →
  • Terminated NCT NCT00127036

    Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 65 participants Est. completion 2010-12 12 sites
    Other conditions: Adenocarcinoma, Colon Cancer
    View official trial listing →
  • Completed NCT NCT00142038

    Docetaxel and Capecitabine in Advanced Gastric Cancer

    Not yet reported Charite University, Berlin, Germany 80 participants Est. completion 2007-12 1 site
    Other conditions: Stomach Neoplasm, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00142350

    A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer

    Not yet reported Japan Clinical Oncology Group 690 participants Est. completion 2007-01 34 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00177307

    Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer

    Not yet reported University of Pittsburgh 40 participants Est. completion 2012-02 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00190515

    A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

    Not yet reported Haruhiko Fukuda 1101 participants Est. completion 2011-11 48 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00193609

    Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

    Not yet reported SCRI Development Innovations, LLC 48 participants Est. completion 2009-01 10 sites
    Other conditions: Neoplasms, Unknown Primary
    View official trial listing →
  • Completed NCT NCT00200200

    Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 73 participants Est. completion 2025-03-13 5 sites Stand-alone
    Other conditions: Hepatic Metastases, Colon Cancer, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00215514

    Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma

    Not yet reported Dana-Farber Cancer Institute 25 participants Est. completion 2014-07 3 sites Stand-alone
    Other conditions: Stomach Cancer, Gastric Cancer, Gastro-esophageal Junction Cancer
    View official trial listing →
  • Completed NCT NCT00215644

    Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer

    Not yet reported Merck KGaA, Darmstadt, Germany 72 participants Est. completion 2008-08-31 22 sites
    Other conditions: Esophageal Cancer, Gastric Cancer
    View official trial listing →
  • Terminated NCT NCT00216086

    Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

    Not yet reported Gabi Chiorean, MD 22 participants Est. completion 2008-05 9 sites
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00220168

    Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours

    Not yet reported Royal Marsden NHS Foundation Trust 33 participants 1 site
    Other conditions: Upper Gastrointestinal Tumours
    View official trial listing →
  • Terminated NCT NCT00235235

    A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

    Hoosier Cancer Research Network 80 participants Est. completion 2010-12 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00258323

    Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer

    Not yet reported Case Comprehensive Cancer Center 80 participants Est. completion 2010-02 1 site
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00262808

    GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer

    Not yet reported University of Rochester 50 participants Est. completion 2006-09 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Suspended NCT NCT00264472

    A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

    Not yet reported Adherex Technologies, Inc. 60 participants 1 site
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT00268398

    Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 284 participants 32 sites Stand-alone
    Other conditions: Colorectal Cancer, Metastatic Cancer, Chemotherapy
    View official trial listing →
  • Completed NCT NCT00275210

    MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

    Not yet reported Sanofi 2246 participants Est. completion 2003-04 19 sites
    Other conditions: Colonic Neoplasms
    View official trial listing →
  • Completed NCT NCT00280618

    Oxaliplatin in Unresectable Hepatocellular Carcinoma

    Not yet reported Sanofi
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Completed NCT NCT00297128

    Preoperative Chemoradiation With Capecitabine and Cetuximab

    Not yet reported Austrian Breast & Colorectal Cancer Study Group 31 participants Est. completion 2011-11 10 sites
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00303758

    Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

    Not yet reported Federation Francophone de Cancerologie Digestive 202 participants Est. completion 2012-03 46 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00327743

    Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

    Not yet reported, Not yet reported Sanofi 34 participants Est. completion 2009-03 2 sites
    Other conditions: Breast Cancer, Cancer
    View official trial listing →
  • Approved For Marketing NCT NCT00338247

    EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

    Novartis Est. completion 2015-03 453 sites
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Terminated NCT NCT00347438

    Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer

    Not yet reported University of Chicago 18 participants Est. completion 2013-03 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00352118

    Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 4 participants Est. completion 2008-04 1 site Stand-alone
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00353262

    A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.

    Not yet reported Hoffmann-La Roche 36 participants Est. completion 2008-04 3 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00354601

    Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer

    Not yet reported Wake Forest University Health Sciences 2 participants Est. completion 2008-07 1 site
    Other conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00381706

    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 245 participants Est. completion 2014-10-15 227 sites Stand-alone
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00382720

    Docetaxel and Oxaliplatin in Gastric Cancer

    Not yet reported Sanofi 275 participants Est. completion 2010-04 12 sites Stand-alone
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Terminated NCT NCT00385021

    ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

    Not yet reported Southwestern Regional Medical Center 20 participants Est. completion 2007-09 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00390416

    Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma

    Not yet reported Memorial Sloan Kettering Cancer Center 48 participants Est. completion 2012-01 5 sites Stand-alone
    Other conditions: Stomach Neoplasms, Esophageal Neoplasms
    View official trial listing →
  • Completed NCT NCT00393822

    A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

    Not yet reported, Not yet reported Amgen 100 participants Est. completion 2014-03
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT00398320

    Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

    Not yet reported Pamela L. Kunz 40 participants Est. completion 2012-10 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Status unknown NCT NCT00408551

    Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

    Not yet reported Goshen Health System 20 participants 1 site Stand-alone
    Other conditions: Colorectal Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT00408694

    Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

    Not yet reported National Cancer Institute (NCI) 46 participants Est. completion 2011-12-15 108 sites Stand-alone
    Other conditions: Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7, Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7
    View official trial listing →
  • Completed NCT NCT00427713

    Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

    Not yet reported Cancer Research UK 800 participants 72 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00429299

    Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer

    Not yet reported GlaxoSmithKline 121 participants Est. completion 2012-06 17 sites Stand-alone
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT00433550

    Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 33 participants Est. completion 2016-05 115 sites
    Other conditions: Small Intestine Adenocarcinoma, Recurrent Small Intestine Cancer
    View official trial listing →
  • Completed NCT NCT00436241

    A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.

    Not yet reported Hoffmann-La Roche 45 participants Est. completion 2010-11 13 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Withdrawn NCT NCT00450515

    Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology Est. completion 2009-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00454636

    A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.

    Not yet reported Hoffmann-La Roche 158 participants Est. completion 2010-07 51 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00460265

    Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer

    Not yet reported Amgen 658 participants Est. completion 2012-05
    Other conditions: Recurrent and/or Metastatic Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00477711

    A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer

    Not yet reported Peking University 41 participants Est. completion 2009-02 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00502567

    A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors

    Not yet reported AstraZeneca 104 participants Est. completion 2011-06 3 sites
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Terminated NCT NCT00503321

    Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma

    Not yet reported, Not yet reported Eastern Network of Cancer Immunological Therapy, Japan 13 participants Est. completion 2011-08 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Terminated NCT NCT00506168

    Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

    Not yet reported National Cancer Center, Korea 37 participants Est. completion 2007-07 1 site
    Other conditions: Colorectal Neoplasms, Secondary, Drug Therapy, Combination
    View official trial listing →
  • Status unknown NCT NCT00509561

    Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

    Not yet reported, Not yet reported Wales Cancer Trials Unit 259 participants 55 sites
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00511446

    Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer

    Not yet reported Martin-Luther-Universität Halle-Wittenberg 56 participants Est. completion 2013-01 10 sites
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Completed NCT NCT00513383

    Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

    Not yet reported Massachusetts General Hospital 34 participants Est. completion 2012-10 2 sites Stand-alone
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Withdrawn NCT NCT00524069

    Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

    Not yet reported Roswell Park Cancer Institute
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00526669

    Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

    Not yet reported GlaxoSmithKline 68 participants Est. completion 2015-01 22 sites
    Other conditions: Neoplasms, Gastrointestinal Tract
    View official trial listing →
  • Completed NCT NCT00536809

    Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

    Not yet reported GlaxoSmithKline 12 participants Est. completion 2008-10-31 1 site
    Other conditions: Neoplasms, Colorectal
    View official trial listing →
  • Terminated NCT NCT00541112

    Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

    Not yet reported UNICANCER 19 participants Est. completion 2010-01-29 10 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00544505

    Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)

    Not yet reported King Faisal Specialist Hospital & Research Center 10 participants Est. completion 2013-09
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00545545

    Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma

    Not yet reported, Not yet reported HiberCell, Inc. 32 participants Est. completion 2009-12 2 sites
    Other conditions: Recurrent Colorectal Carcinoma, Progressive Colorectal Carcinoma
    View official trial listing →
  • Terminated NCT NCT00546364

    Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer

    Not yet reported R-Pharm 62 participants Est. completion 2010-03 60 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00548548

    A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer

    Not yet reported Genentech, Inc. 774 participants Est. completion 2013-11 13 sites Stand-alone
    Other conditions: Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT00563927

    Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

    Not yet reported Hospital Authority, Hong Kong 340 participants Est. completion 2009-10 4 sites
    Other conditions: Nasopharyngeal Neoplasms, Carcinoma, Squamous Cell
    View official trial listing →
  • Completed NCT NCT00565448

    Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

    Not yet reported Sanofi 75 participants Est. completion 2012-01 26 sites Stand-alone
    Other conditions: Nasopharyngeal Neoplasms, Carcinoma
    View official trial listing →
  • Suspended NCT NCT00568529

    Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

    Not yet reported Fudan University 30 participants Est. completion 2010-02 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Terminated NCT NCT00570908

    Brain Mets - Capecitabine Plus Sunitinib and WBRT

    Not yet reported Baylor Breast Care Center 12 participants Est. completion 2013-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00580983

    Optimized Intensity Modulated Irradiation for Head and Neck Cancer

    Not yet reported University of Michigan Rogel Cancer Center 90 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Terminated NCT NCT00599131

    Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)

    Not yet reported University of Michigan Rogel Cancer Center 4 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Cancer of Larynx
    View official trial listing →
  • Completed NCT NCT00602602

    Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 19 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00607685

    5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy

    Not yet reported Singapore National Eye Centre 50 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Glaucoma, Trabeculectomy, Wound Healing
    View official trial listing →
  • Completed NCT NCT00609284

    Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux

    Not yet reported Groupe Oncologie Radiotherapie Tete et Cou 406 participants Est. completion 2019-03-26 5 sites
    Other conditions: HNSCC
    View official trial listing →
  • Completed NCT NCT00618124

    A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together

    Not yet reported Pfizer 77 participants Est. completion 2008-07 3 sites
    Other conditions: Solid Tumors, Breast Cancer, Neoplasms
    View official trial listing →
  • Completed NCT NCT00631410

    Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer

    Not yet reported Pfizer 12 participants Est. completion 2010-03 3 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00632333

    Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer

    Not yet reported Teikyo University 9 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00668863

    Study Of Sunitinib With FOLFIRI In Colorectal Cancer

    Not yet reported Pfizer 71 participants Est. completion 2010-09 10 sites Stand-alone
    Other conditions: Unresectable or Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00685763

    Proton Therapy for Unresectable Cancer (CA) of Pancreas

    Not yet reported University of Florida 13 participants Est. completion 2017-06-29 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00706069

    Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer

    Not yet reported Hellenic Oncology Research Group 40 participants Est. completion 2009-07 4 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00776724

    Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm

    Not yet reported National Taiwan University Hospital 166 participants Est. completion 2017-04-19 1 site
    Other conditions: Breast Cancer, Chemotherapy
    View official trial listing →
  • Terminated NCT NCT00779311

    A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer

    Not yet reported Accelerated Community Oncology Research Network 8 participants Est. completion 2011-03 3 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00816816

    Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma

    Not yet reported Fudan University 64 participants Est. completion 2010-06 1 site
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Completed NCT NCT00829166

    A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

    Not yet reported Hoffmann-La Roche 991 participants Est. completion 2015-09 323 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00831181

    Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer

    Not yet reported Beth Israel Medical Center 27 participants Est. completion 2009-11 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00838370

    Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines

    Not yet reported The Netherlands Cancer Institute 22 participants Est. completion 2011-10 3 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT00847119

    Xeloda and Bevacizumab to Treat Rectal Cancer

    Not yet reported Institut Català d'Oncologia 43 participants Est. completion 2015-02 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00849550

    Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.

    Not yet reported Herbert Hurwitz 32 participants Est. completion 2012-12 3 sites
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific, Cancer
    View official trial listing →
  • Completed NCT NCT00849615

    Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

    Not yet reported Krankenhaus Nordwest 252 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction
    View official trial listing →
  • Completed NCT NCT00865709

    Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

    Not yet reported Bayer 198 participants Est. completion 2012-02 116 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00868491

    Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer

    Not yet reported Institute of Oncology Ljubljana 30 participants Est. completion 2011-10-30 1 site Stand-alone
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Terminated NCT NCT00881504

    A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma

    Not yet reported Georgetown University 9 participants Est. completion 2011-12 1 site
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Terminated NCT NCT00889187

    Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 10 participants Est. completion 2011-12-30 3 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00909402

    A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

    Not yet reported Bristol-Myers Squibb 39 participants Est. completion 2012-11 6 sites
    Other conditions: Stomach Neoplasms, Esophageal Neoplasms
    View official trial listing →
  • Completed NCT NCT00920868

    XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib

    Not yet reported Herbert Hurwitz, MD 22 participants Est. completion 2014-08 2 sites
    Other conditions: Solid Tumor, Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00940303

    OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 97 participants Est. completion 2014-02 17 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00941135

    Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab

    Not yet reported Fundacion Miguel Servet 70 participants Est. completion 2013-05 4 sites
    Other conditions: Laryngeal Neoplasms
    View official trial listing →
  • Completed NCT NCT00962312

    Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer

    Not yet reported Cancer Trials Ireland 9 participants 9 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00967031

    Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases

    Not yet reported UNICANCER 45 participants 1 site
    Other conditions: Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Status unknown NCT NCT00999700

    Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin

    Not yet reported Gruppo Oncologico del Nord-Ovest 282 participants Est. completion 2021-12 21 sites Stand-alone
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Completed NCT NCT01013740

    Lapatinib in Combination With Vinorelbine

    Not yet reported Novartis Pharmaceuticals 112 participants Est. completion 2016-03-01 53 sites
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01032967

    Surgery or Chemoradiation for Esophageal Cancer

    Not yet reported Chinese University of Hong Kong 40 participants Est. completion 2009-06
    Other conditions: Esophageal Cancers
    View official trial listing →
  • Completed NCT NCT01037998

    UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

    Not yet reported Taipei Veterans General Hospital, Taiwan 115 participants Est. completion 2009-12 1 site
    Other conditions: Non-Small-Cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT01039181

    Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

    Not yet reported National Science and Technology Development Agency, Thailand 28 participants Est. completion 2012-10 1 site
    Other conditions: Advanced Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT01043484

    Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer

    Not yet reported Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 90 participants Est. completion 2016-08 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01044433

    Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck

    Not yet reported Abramson Cancer Center at Penn Medicine 44 participants Est. completion 2017-03-03 1 site
    Other conditions: Head and Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity
    View official trial listing →
  • Active, not recruiting NCT NCT01061515

    Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer

    Not yet reported Washington University School of Medicine 21 participants Est. completion 2027-09-27 1 site
    Other conditions: Carcinoma
    View official trial listing →
  • Completed NCT NCT01071655

    Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer

    Not yet reported Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 195 participants Est. completion 2013-11 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01080547

    Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer

    Not yet reported Zhejiang University 374 participants Est. completion 2014-12 2 sites
    Other conditions: Length of Stay, Complications, Adverse Drug Event, Quality of Life, Hospital Costs
    View official trial listing →
  • Completed NCT NCT01108107

    Neoadjuvant Treatment of Colon Cancer

    Not yet reported Vejle Hospital 76 participants Est. completion 2015-03 3 sites
    Other conditions: Colon Cancer
    View official trial listing →
  • Withdrawn NCT NCT01142414

    Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01158274

    RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

    Not yet reported National Cancer Institute (NCI) 30 participants 2 sites
    Obstructive sleep apnea Other conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma, AIDS-related Lymphoblastic Lymphoma, AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, AIDS-related Small Noncleaved Cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, HER2-negative Breast Cancer, HIV-associated Hodgkin Lymphoma, Intraocular Lymphoma, Male Breast Cancer, Nodal Marginal Zone B-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Breast Cancer, Recurrent Colon Cancer, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Rectal Cancer, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Colon Cancer, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Rectal Cancer, Stage III Small Lymphocytic Lymphoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Breast Cancer, Stage IV Colon Cancer, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Rectal Cancer, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01163396

    First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

    Not yet reported Gruppo Oncologico del Nord-Ovest 57 participants Est. completion 2010-04 Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Status unknown NCT NCT01167049

    Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

    Not yet reported Peking University Cancer Hospital & Institute 60 participants Est. completion 2013-12 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01185171

    Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer

    Not yet reported University of Chicago 70 participants Est. completion 2018-08 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Status unknown NCT NCT01198392

    Trial of S-1 Plus Cisplatin in Gastric Cancer

    Not yet reported Sun Yat-sen University 270 participants Est. completion 2011-12 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01199432

    Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer

    Not yet reported Tao OUYANG 501 participants Est. completion 2014-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01205022

    Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01206465

    Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors

    Not yet reported University of Nebraska 29 participants Est. completion 2017-06-01 1 site Stand-alone
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT01206530

    FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 50 participants Est. completion 2017-09 1 site
    Other conditions: Rectal Cancer, Colon Cancer, Metastasis, Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT01214343

    Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

    Not yet reported Ministry of Health, Labour and Welfare, Japan 190 participants Est. completion 2013-09 30 sites Stand-alone
    Other conditions: Advanced Hepatocellular Carcinoma, Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms
    View official trial listing →
  • Terminated NCT NCT01220128

    Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

    Not yet reported GlaxoSmithKline 66 participants Est. completion 2014-11-14 36 sites Stand-alone
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT01226719

    FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

    Not yet reported SCRI Development Innovations, LLC 15 participants Est. completion 2014-03 15 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01238939

    Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

    Not yet reported Nippon Kayaku Co., Ltd. 35 participants Est. completion 2014-03 1 site
    Other conditions: Advanced Solid Tumors, Metastatic Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT01245582

    Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients

    Not yet reported Sanofi Est. completion 2015-08
    Other conditions: Hepatic Neoplasm Malignant
    View official trial listing →
  • Status unknown NCT NCT01245959

    Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

    Not yet reported Sun Yat-sen University 476 participants Est. completion 2018-04 1 site Stand-alone
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Completed NCT NCT01290926

    Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer

    Not yet reported Jules Bordet Institute 97 participants Est. completion 2016-01 7 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01307956

    Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

    Not yet reported University of Nebraska 11 participants Est. completion 2015-12-23 1 site Stand-alone
    Other conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Adenocarcinoma, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT01312857

    Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 75 participants Est. completion 2024-07-15 8 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01315990

    FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema

    Not yet reported Dr. Carl Schimanski 165 participants Est. completion 2018-03 1 site
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT01319877

    An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer

    Hoffmann-La Roche 609 participants Est. completion 2015-03 24 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01320683

    Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

    Not yet reported City of Hope Medical Center 1 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01325649

    Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma

    Johannes Gutenberg University Mainz 1051 participants Est. completion 2016-09 1 site
    Other conditions: Rectal Cancer Stage II, Rectal Cancer Stage III
    View official trial listing →
  • Completed NCT NCT01326481

    Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer

    Not yet reported, Not yet reported Tracon Pharmaceuticals Inc. 19 participants Est. completion 2014-12 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01331928

    Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer

    Not yet reported Taipei Veterans General Hospital, Taiwan 51 participants 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT01348009

    Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer

    Not yet reported, Not yet reported Genta Incorporated 63 participants Est. completion 2014-01 1 site
    Other conditions: Gastric Carcinoma
    View official trial listing →
  • Completed NCT NCT01358812

    FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer

    Not yet reported Gruppo Oncologico del Nord-Ovest 37 participants 10 sites Stand-alone
    Other conditions: Metastatic Colo-rectal Cancer
    View official trial listing →
  • Terminated NCT NCT01359007

    FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

    Not yet reported University of Oklahoma 5 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Adenocarcinoma of Pancreas
    View official trial listing →
  • Completed NCT NCT01362361

    TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)

    Not yet reported Martin-Luther-Universität Halle-Wittenberg 54 participants Est. completion 2016-12 12 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01375816

    Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 55 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01396668

    Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer

    Not yet reported Seoul National University Hospital 35 participants Est. completion 2011-06 2 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT01467921

    Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma

    Not yet reported Samsung Medical Center 68 participants 1 site Stand-alone
    Other conditions: Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01471470

    Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

    Not yet reported Asan Medical Center 31 participants Est. completion 2018-07 1 site
    Other conditions: Advanced Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01472770

    A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer

    Not yet reported Vejle Hospital 49 participants Est. completion 2014-05 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01474187

    Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer

    Not yet reported Fudan University 60 participants Est. completion 2012-12 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01488552

    Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

    Not yet reported, Not yet reported Pancreatic Cancer Research Team 60 participants Est. completion 2016-08 5 sites Stand-alone
    Other conditions: Stage IV Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01490866

    A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

    Not yet reported SCRI Development Innovations, LLC 70 participants Est. completion 2015-07 12 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01494155

    Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer

    Not yet reported Massachusetts General Hospital 50 participants Est. completion 2018-09-16 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01507103

    Tecemotide (L-BLP25) in Rectal Cancer

    Not yet reported Merck KGaA, Darmstadt, Germany 124 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01516944

    Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

    Not yet reported, Not yet reported Hebei Medical University 749 participants Est. completion 2018-12 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT01533324

    S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

    Not yet reported Second Military Medical University 32 participants Est. completion 2016-12 1 site
    Other conditions: Carcinoma, Liver Diseases, Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT01590719

    A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer

    Not yet reported Hoffmann-La Roche 123 participants Est. completion 2014-10 36 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Terminated NCT NCT01627379

    Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer

    Not yet reported AIO-Studien-gGmbH 300 participants Est. completion 2017-05 1 site Stand-alone
    Other conditions: Esophageal Squamous Cell Cancer
    View official trial listing →
  • Completed NCT NCT01677884

    Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 10 participants Est. completion 2016-02 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT01715233

    Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Metastatic Esophageal Cancer, Gastroesophageal Cancer, Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01740648

    Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 19 participants Est. completion 2021-09-29 4 sites Stand-alone
    Other conditions: Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer, Stage IIC Rectal Cancer, Stage IIIA Rectal Cancer, Stage IIIB Rectal Cancer, Stage IIIC Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01748773

    A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer

    Not yet reported Hoffmann-La Roche 34 participants Est. completion 2017-06-15 9 sites
    Other conditions: Gastric Cancer, Gastroesophageal Junction Cancer
    View official trial listing →
  • Completed NCT NCT01749397

    Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer

    Not yet reported National Cancer Institute (NCI) 29 participants Est. completion 2019-11-21 5 sites
    Other conditions: Stage IV Fallopian Tube Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Primary Peritoneal Cancer AJCC v7
    View official trial listing →
  • Terminated NCT NCT01759238

    Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 1 participants Est. completion 2014-10 1 site
    Other conditions: Colorectal Cancer, Metastases
    View official trial listing →
  • Completed NCT NCT01776307

    A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

    Not yet reported Sumitomo Pharma America, Inc. 200 participants Est. completion 2020-04 13 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01787006

    Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer

    Not yet reported University Hospital Schleswig-Holstein 74 participants Est. completion 2018-09-06 1 site Stand-alone
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT01814501

    Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

    Not yet reported John Hays 16 participants Est. completion 2018-08-06 2 sites Stand-alone
    Other conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IV Colon Cancer, Stage IV Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01827553

    Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

    Not yet reported University of Erlangen-Nürnberg Medical School 830 participants Est. completion 2023-11-08 23 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT01832948

    Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer

    Not yet reported Zhejiang Cancer Hospital 30 participants Est. completion 2015-01 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01843452

    Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal

    Not yet reported Centre Hospitalier Universitaire Vaudois 8 participants Est. completion 2016-05 4 sites
    Other conditions: Carcinoma of Anal Canal
    View official trial listing →
  • Status unknown NCT NCT01843829

    A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer

    Not yet reported Lisette Nixon 85 participants Est. completion 2016-05 12 sites
    Other conditions: Oesophageal Cancer
    View official trial listing →
  • Completed NCT NCT01846650

    A Bioequivalence Study of Capecitabine Tablets

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 36 participants Est. completion 2013-06 1 site
    Other conditions: Metastatic Breast Cancer or Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01855828

    Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer

    Not yet reported Yale University 50 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Her2-Positive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01858662

    Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 4 participants Est. completion 2015-11 7 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01869192

    Phase II Trial for Large ER-Negative Breast Cancers

    Not yet reported University of Colorado, Denver 72 participants Est. completion 2010-08-21 1 site
    Other conditions: Malignant Neoplasm of Female Breast
    View official trial listing →
  • Status unknown NCT NCT01880658

    Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer

    Not yet reported Sun Yat-sen University 100 participants Est. completion 2019-05 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT01882868

    A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan

    Not yet reported Sanofi 62 participants Est. completion 2015-08 19 sites
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT01896531

    A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer

    Not yet reported Genentech, Inc. 153 participants Est. completion 2021-01-26 34 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT01917279

    Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC

    Not yet reported Binghe Xu 280 participants Est. completion 2021-07 1 site
    Other conditions: Breast Neoplasms, Neoplasms by Site, Neoplasm Metastasis, Breast Diseases, Skin Diseases
    View official trial listing →
  • Status unknown NCT NCT01917578

    Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction

    Not yet reported Shandong Cancer Hospital and Institute 4 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01939054

    Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

    Not yet reported Chinese Academy of Medical Sciences 90 participants Est. completion 2016-09 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01964534

    Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 114 participants Est. completion 2017-07 15 sites
    Other conditions: Metastatic Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01966471

    A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

    Not yet reported Hoffmann-La Roche 1846 participants Est. completion 2021-06-04 295 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01967875

    A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer

    Not yet reported China Medical University, China 27 participants Est. completion 2016-05 7 sites
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Completed NCT NCT02022033

    BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

    Not yet reported Brown University 25 participants Est. completion 2022-03-17 2 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT02028507

    Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors

    Not yet reported Spanish Breast Cancer Research Group 693 participants Est. completion 2021-01-11 37 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02028806

    mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer

    Not yet reported Yuhong Li 40 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Metastatic Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT02043821

    Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker

    Not yet reported Beijing Chao Yang Hospital 80 participants
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02048540

    Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell

    Not yet reported, Not yet reported Chinese PLA General Hospital 86 participants Est. completion 2013-12 1 site
    Other conditions: Locally Advanced Gastric Carcinoma
    View official trial listing →
  • Completed NCT NCT02052960

    CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer

    Not yet reported Glycotope GmbH 240 participants Est. completion 2017-10-04 34 sites Stand-alone
    Other conditions: Carcinoma, Squamous Cell of Head and Neck
    View official trial listing →
  • Completed NCT NCT02059499

    Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

    Not yet reported AIDS Malignancy Consortium 91 participants Est. completion 2024-05-02 13 sites Stand-alone
    Other conditions: Anal Intraepithelial Neoplasia, High-grade Squamous Intraepithelial Lesion, HIV Infection
    View official trial listing →
  • Status unknown NCT NCT02071069

    Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer

    Not yet reported Tianshu Liu 54 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Incurable Colorectal Cancer, RAS-wild-type
    View official trial listing →
  • Completed NCT NCT02129257

    Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer

    Not yet reported Hellenic Cooperative Oncology Group 73 participants Est. completion 2017-09-25 18 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02135042

    Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

    Not yet reported, Not yet reported NRG Oncology 924 participants Est. completion 2031-12-01 213 sites
    Other conditions: EBV Infection, Stage II Nasopharyngeal Carcinoma AJCC v7, Stage III Nasopharyngeal Carcinoma AJCC v7, Stage IVA Nasopharyngeal Carcinoma AJCC v7, Stage IVB Nasopharyngeal Carcinoma AJCC v7
    View official trial listing →
  • Terminated NCT NCT02141295

    A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 197 participants Est. completion 2017-02-01 39 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02199236

    Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

    Not yet reported Memorial Sloan Kettering Cancer Center 15 participants Est. completion 2024-10-29 7 sites
    Other conditions: Rectal or Anal Cancer
    View official trial listing →
  • Completed NCT NCT02205047

    Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 172 participants Est. completion 2024-12-31 48 sites Stand-alone
    Other conditions: Malignant Neoplasm of Stomach, Malignant Neoplasm of Cardio-esophageal Junction of Stomach, Epidermal Growth Factor Receptor (EGFR) Protein Overexpression
    View official trial listing →
  • Completed NCT NCT02210364

    Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).

    Not yet reported PharmaMar 81 participants Est. completion 2016-10 2 sites
    Other conditions: Metastatic Breast Cancer, Pancreatic Cancer, Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02242747

    Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis

    Not yet reported University of Sao Paulo 100 participants Est. completion 2014-08 1 site
    Other conditions: Actinic Keratosis
    View official trial listing →
  • Completed NCT NCT02244632

    Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer

    Not yet reported, Not yet reported Isofol Medical AB 105 participants Est. completion 2020-01-30 10 sites Stand-alone
    Other conditions: Colorectal Neoplasm
    View official trial listing →
  • Status unknown NCT NCT02250209

    T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy

    Not yet reported Chinese PLA General Hospital 40 participants Est. completion 2017-12 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT02284529

    Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer

    Not yet reported Sinphar Pharmaceutical Co., Ltd 20 participants Est. completion 2014-09 1 site
    Other conditions: Stage-Ⅱ Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02287129

    Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction

    Not yet reported Technical University of Munich 75 participants Est. completion 2020-08-07 1 site
    Other conditions: Adenocarcinoma of the Esophagogastric Junction
    View official trial listing →
  • Completed NCT NCT02314182

    GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis

    Not yet reported Hospices Civils de Lyon 5 participants Est. completion 2018-02-27 3 sites
    Other conditions: Rectal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT02316535

    Low-dose Capecitabine Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colorectal Cancer

    Not yet reported West China Hospital 710 participants Est. completion 2018-05 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT02353858

    Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer

    Not yet reported University Hospital Tuebingen 78 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Rectal Cancer, Locally Advanced Rectal Cancer, Hyperthermia, Hyperthermic Radiochemotherapy, Hyperthermic Chemoradiotherapy, Deep Regional Hyperthermia
    View official trial listing →
  • Status unknown NCT NCT02371304

    Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers

    Not yet reported Amsterdam UMC, location VUmc 302 participants Est. completion 2023-01 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02380131

    Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis

    Not yet reported Hebei Medical University 60 participants Est. completion 2017-12 1 site
    Other conditions: HER-2 Positive Gastric Cancer, Liver Metastasis
    View official trial listing →
  • Completed NCT NCT02383810

    Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)

    Not yet reported Helsinn Healthcare SA 498 participants Est. completion 2016-02 54 sites
    Other conditions: Drug and/or Toxin-induced Diarrhea
    View official trial listing →
  • Completed NCT NCT02393755

    Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Roswell Park Cancer Institute 42 participants Est. completion 2021-05-18 2 sites
    Other conditions: Colon Adenocarcinoma, Rectal Adenocarcinoma, Recurrent Colon Carcinoma, Recurrent Rectal Carcinoma, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02394834

    An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

    Takeda 757 participants Est. completion 2027-09-30 151 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT02414165

    The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma

    Not yet reported, Not yet reported Tocagen Inc. 403 participants Est. completion 2019-12-20 67 sites
    Other conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma
    View official trial listing →
  • Terminated NCT NCT02420509

    Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

    University of California, San Diego 2 participants Est. completion 2019-04-02 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT02486497

    Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining

    Not yet reported Seoul National University Hospital 40 participants Est. completion 2017-05 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT02508077

    FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

    Not yet reported City of Hope Medical Center 1 participants Est. completion 2017-09-13 4 sites Stand-alone
    Other conditions: Recurrent Colorectal Carcinoma, Stage IVA Colorectal Cancer, Stage IVB Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02528110

    Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

    Not yet reported Wuhan University 100 participants Est. completion 2020-03-10 1 site
    Other conditions: Malignant Neoplasm of Stomach
    View official trial listing →
  • Completed NCT NCT02545504

    Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

    Not yet reported Gilead Sciences 432 participants Est. completion 2019-05-15 134 sites Stand-alone
    Other conditions: Gastric Adenocarcinoma
    View official trial listing →
  • Terminated NCT NCT02550743

    BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study

    Not yet reported howard safran 7 participants Est. completion 2018-11-16 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02560298

    Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer

    Not yet reported ECOG-ACRIN Cancer Research Group 91 participants Est. completion 2023-08 1 site Stand-alone
    Other conditions: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma, Metastatic Anal Canal Carcinoma, Recurrent Anal Canal Carcinoma, Stage IIIB Anal Canal Cancer, Stage IV Anal Canal Cancer
    View official trial listing →
  • Terminated NCT NCT02576665

    A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)

    Not yet reported Tocagen Inc. 21 participants Est. completion 2019-12-20 3 sites
    Other conditions: Colorectal Cancer, Triple Negative Breast Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, Head and Neck Cancer, Ovarian Cancer, Lymphoma, Sarcoma, Bladder Cancer, Melanoma, IDH1 Mutated Solid Tumors, IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)
    View official trial listing →
  • Withdrawn NCT NCT02580253

    Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation

    Not yet reported Zhejiang University Est. completion 2018-12 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT02595424

    Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

    Not yet reported ECOG-ACRIN Cancer Research Group 67 participants Est. completion 2029-01-01 673 sites
    Other conditions: Gastric Neuroendocrine Carcinoma, Intestinal Neuroendocrine Carcinoma, Pancreatic Neuroendocrine Carcinoma
    View official trial listing →
  • Completed NCT NCT02605265

    Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1

    Not yet reported Fudan University 356 participants Est. completion 2023-06 1 site
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Completed NCT NCT02608073

    A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

    Not yet reported Hoffmann-La Roche 45 participants Est. completion 2009-11 9 sites
    Other conditions: Nasopharyngeal Cancer
    View official trial listing →
  • Completed NCT NCT02648425

    Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine

    Not yet reported ASLAN Pharmaceuticals 31 participants Est. completion 2017-09-15 3 sites Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Terminated NCT NCT02716896

    Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

    Not yet reported The University of Texas Health Science Center at San Antonio 2 participants Est. completion 2018-03-26 1 site
    Other conditions: Muscle Invasive Bladder Cancer
    View official trial listing →
  • Status unknown NCT NCT02717923

    A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer

    Not yet reported Huazhong University of Science and Technology 50 participants Est. completion 2019-06 1 site Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT02720601

    Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

    Not yet reported New Mexico Cancer Research Alliance Est. completion 2020-03 1 site
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT02730546

    Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

    Not yet reported, Not yet reported Mayo Clinic 31 participants Est. completion 2023-10-31 2 sites Stand-alone
    Other conditions: Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7, Stage II Gastric Cancer AJCC v7, Stage IIA Gastric Cancer AJCC v7, Stage IIB Gastric Cancer AJCC v7, Stage IIIA Gastric Cancer AJCC v7, Stage IIIB Gastric Cancer AJCC v7
    View official trial listing →
  • Active, not recruiting NCT NCT02734290

    Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

    Not yet reported, Not yet reported Providence Health & Services 29 participants Est. completion 2026-12 2 sites
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT02742051

    A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40 participants Est. completion 2020-03-14 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02767661

    Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 263 participants Est. completion 2023-08-25 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02777437

    Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer

    Not yet reported, Not yet reported Fudan University 1960 participants Est. completion 2021-10
    Other conditions: Colonic Neoplasms
    View official trial listing →
  • Completed NCT NCT02834559

    Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.

    Not yet reported Universitätsklinikum Köln 326 participants Est. completion 2020-06-15 13 sites
    Other conditions: Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR)
    View official trial listing →
  • Status unknown NCT NCT02838238

    X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer

    Not yet reported Peking Union Medical College Hospital 300 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02842125

    Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer

    Not yet reported, Not yet reported MultiVir, Inc. 4 participants Est. completion 2020-05-08 1 site
    Other conditions: Metastatic Solid Tumor Cancer, Recurrent Head and Neck Cancer
    View official trial listing →
  • Withdrawn NCT NCT02856867

    Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC
    Other conditions: Esophagogastric Adenocarcinoma, Metastatic Disease, No Previous Chemotherapy for Metastatic Esophagogastric Cancer
    View official trial listing →
  • Completed NCT NCT02861300

    CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer

    Not yet reported, Not yet reported David Bajor, MD 50 participants Est. completion 2023-01-10 2 sites
    Other conditions: Colorectal Cancer, Colon Cancer, Rectal Cancer, Solid Tumor
    View official trial listing →
  • Completed NCT NCT02864849

    Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

    Not yet reported Peking University Cancer Hospital & Institute 81 participants Est. completion 2019-06 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Suspended NCT NCT02897050

    Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 170 participants Est. completion 2024-09 4 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02912559

    Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

    Not yet reported National Cancer Institute (NCI) 712 participants Est. completion 2026-12-18 1049 sites Stand-alone
    Other conditions: Colon Adenocarcinoma, DNA Repair Disorder, Lynch Syndrome, Stage III Colon Cancer AJCC v8
    View official trial listing →
  • Withdrawn NCT NCT02915172

    Lenvatinib and Capecitabine in Patients With Advanced Malignancies

    Not yet reported M.D. Anderson Cancer Center
    Other conditions: Advanced Cancer, Malignant Neoplasm of Breast, Malignant Neoplasms of Bone and Articular Cartilage, Malignant Neoplasms of Digestive Organs, Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System, Malignant Neoplasms of Female Genital Organs, Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites, Malignant Neoplasms of Independent (Primary) Multiple Sites, Malignant Neoplasms of Lip Oral Cavity and Pharynx, Malignant Neoplasms of Male Genital Organs, Malignant Neoplasms of Mesothelial and Soft Tissue, Malignant Neoplasms of Respiratory and Intrathoracic Organs, Malignant Neoplasms of Thyroid and Other Endocrine Glands, Malignant Neoplasms of Urinary Tract
    View official trial listing →
  • Active, not recruiting NCT NCT02931890

    Multicentric Randomised Trial for Resectable Gastric Cancer

    Not yet reported The Netherlands Cancer Institute 207 participants Est. completion 2029-03 28 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT02980510

    Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients

    Not yet reported UNICANCER 219 participants Est. completion 2026-01 6 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03037541

    Cryosurgery and Cream Combination for Actinic Keratosis

    Not yet reported Wake Forest University Health Sciences 60 participants Est. completion 2013-10-29 1 site Stand-alone
    Other conditions: Actinic Keratosis
    View official trial listing →
  • Withdrawn NCT NCT03037736

    Outpatient Performed Pterygium Surgery Study

    Not yet reported University of California, San Francisco Est. completion 2020-03-01
    Other conditions: Pterygium of Conjunctiva and Cornea
    View official trial listing →
  • Status unknown NCT NCT03044730

    Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery

    Not yet reported Northwestern University 30 participants Est. completion 2021-05 2 sites
    Other conditions: Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative, Recurrent Breast Carcinoma, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03045770

    mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA

    Not yet reported Fujian Cancer Hospital 150 participants Est. completion 2019-12-30 1 site Stand-alone
    Other conditions: Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
    View official trial listing →
  • Completed NCT NCT03084809

    Chemotherapy Combined With CIK Treating Colon Cancer

    Not yet reported China Meitan General Hospital 46 participants Est. completion 2014-09-15
    Other conditions: Colorectal Cancer, Cytokine-induced Killer Cells, Postoperative Complications, Survival
    View official trial listing →
  • Completed NCT NCT03084939

    Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer

    Not yet reported Hoffmann-La Roche 351 participants Est. completion 2023-03-14 18 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03085992

    Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer

    Not yet reported Azienda Ospedaliero, Universitaria Pisana 49 participants Est. completion 2018-03-12 4 sites Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT03158610

    Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Ruijin Hospital 20 participants Est. completion 2021-04-28 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03164382

    Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma

    Not yet reported Sun Yat-sen University 262 participants Est. completion 2020-11-30 1 site Stand-alone
    Other conditions: Liver Cancer, Hepatic Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03169738

    QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT03186326

    Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer

    Not yet reported Federation Francophone de Cancerologie Digestive 132 participants Est. completion 2025-03-01 120 sites
    Other conditions: Metastatic Colorectal Cancer, MSI
    View official trial listing →
  • Withdrawn NCT NCT03197584

    QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT03203525

    Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

    Not yet reported M.D. Anderson Cancer Center 38 participants Est. completion 2026-07-22 1 site Stand-alone
    Other conditions: Advanced Malignant Neoplasm, Colorectal Carcinoma Metastatic in the Liver, Metastatic Malignant Neoplasm in the Liver, Refractory Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT03250832

    Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors

    Not yet reported Tesaro, Inc. 111 participants Est. completion 2023-02-13 12 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT03257163

    Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

    Not yet reported Rutgers, The State University of New Jersey 40 participants Est. completion 2026-12-31 4 sites
    Other conditions: Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency, Stage IB Gastric Cancer AJCC v7, Stage II Gastric Cancer AJCC v7, Stage IIA Gastric Cancer AJCC v7, Stage IIB Gastric Cancer AJCC v7, Stage III Gastric Cancer AJCC v7, Stage IIIA Gastric Cancer AJCC v7, Stage IIIB Gastric Cancer AJCC v7, Stage IIIC Gastric Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT03279237

    A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

    Not yet reported Massachusetts General Hospital 25 participants Est. completion 2026-04-01 1 site Stand-alone
    Other conditions: GastroEsophageal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03306901

    Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma

    Not yet reported Samsung Medical Center 240 participants Est. completion 2033-12-31 9 sites Stand-alone
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Terminated NCT NCT03311750

    Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer

    Not yet reported Hellenic Cooperative Oncology Group 23 participants Est. completion 2021-05-20 8 sites Stand-alone
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03323463

    Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

    Not yet reported Memorial Sloan Kettering Cancer Center 316 participants Est. completion 2026-10-31 10 sites Stand-alone
    Other conditions: HPV-Associated Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Neck
    View official trial listing →
  • Withdrawn NCT NCT03342352

    Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

    Not yet reported Incyte Corporation Est. completion 2018-04-20 Stand-alone
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Terminated NCT NCT03368859

    A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab

    Not yet reported AbbVie 70 participants Est. completion 2019-12-18 65 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Withdrawn NCT NCT03374852

    CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2020-10
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT03377842

    Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer

    Not yet reported Sichuan Provincial People's Hospital 100 participants Est. completion 2020-09-01
    Other conditions: Colorectal Cancer, Neoadjuvant Therapy
    View official trial listing →
  • Withdrawn NCT NCT03386838

    An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck

    Not yet reported Bristol-Myers Squibb Est. completion 2018-04-19 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT03403049

    Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

    Not yet reported Montefiore Medical Center 14 participants Est. completion 2019-07-09 2 sites
    Other conditions: Pancreatic Cancer, Cancer
    View official trial listing →
  • Completed NCT NCT03462251

    Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line

    Not yet reported iOMEDICO AG 41 participants Est. completion 2022-11-30 27 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03483038

    A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

    Not yet reported University of Florida 45 participants Est. completion 2026-12 4 sites Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT03504397

    A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

    Not yet reported Astellas Pharma Global Development, Inc. 565 participants Est. completion 2026-09-30 220 sites Stand-alone
    Other conditions: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT03523312

    Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 47 participants Est. completion 2027-04 8 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Withdrawn NCT NCT03536182

    Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2023-07-01 2 sites
    Other conditions: Locally Advanced Pancreatic Adenocarcinoma
    View official trial listing →
  • Withdrawn NCT NCT03563170

    QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2019-08-23 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent
    View official trial listing →
  • Completed NCT NCT03584711

    FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

    Not yet reported Federation Francophone de Cancerologie Digestive 118 participants Est. completion 2025-03-30 124 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT03603834

    Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

    Not yet reported Khon Kaen University 25 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT03615326

    Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

    Not yet reported Merck Sharp & Dohme LLC 738 participants Est. completion 2025-11-12 192 sites
    Other conditions: Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03618758

    Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6

    Not yet reported, Not yet reported Seoul National University Bundang Hospital 35 participants Est. completion 2023-12-02 1 site
    Other conditions: Gastric Cancer Stage IV, Peritoneal Carcinomatosis, Intraperitoneal Paclitaxel, mFOLFOX6
    View official trial listing →
  • Terminated NCT NCT03645876

    SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 12 participants Est. completion 2019-04-18 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT03678428

    FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

    Not yet reported Sun Yat-sen University 92 participants Est. completion 2022-12-31 1 site
    Other conditions: Metastatic Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Status unknown NCT NCT03702491

    Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

    Not yet reported Eastern Hepatobiliary Surgery Hospital 138 participants Est. completion 2020-08-10 1 site
    Other conditions: Gallbladder Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03751176

    Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal

    Not yet reported Grupo Espanol Multidisciplinario del Cancer Digestivo 31 participants Est. completion 2022-11-30 18 sites
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Active, not recruiting NCT NCT03756298

    Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

    Not yet reported National Cancer Center, Korea 284 participants Est. completion 2027-12-31 1 site
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03778593

    FOLFIRINOX for 2nd-line Treatment of BTC

    Not yet reported Dong-A University Hospital 34 participants Est. completion 2021-01-14 1 site Stand-alone
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT03781362

    Study of CPI-100 in Patients With Advanced Tumors

    Not yet reported Coordination Pharmaceuticals, Inc. 36 participants Est. completion 2022-06-21 3 sites
    Other conditions: Advanced Tumors
    View official trial listing →
  • Completed NCT NCT03813784

    A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 885 participants Est. completion 2023-06-07 1 site
    Other conditions: Gastric Cancer, GastroEsophageal Cancer
    View official trial listing →
  • Completed NCT NCT03837977

    Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma

    Not yet reported The Christie NHS Foundation Trust 58 participants Est. completion 2024-11-26 4 sites
    Other conditions: Oncology, Neuroendocrine Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT03840421

    GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

    Not yet reported Sun Yat-sen University 468 participants Est. completion 2028-12-31 1 site
    Other conditions: Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Nasopharyngeal Diseases, Head and Neck Neoplasm
    View official trial listing →
  • Terminated NCT NCT03930771

    Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas

    Not yet reported Weill Medical College of Cornell University 1 participants Est. completion 2021-10-01 1 site Stand-alone
    Other conditions: Recurrent Pituitary Adenomas
    View official trial listing →
  • Status unknown NCT NCT03950154

    Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 198 participants Est. completion 2023-08-01 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03950271

    SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma

    Not yet reported Henan Cancer Hospital 25 participants Est. completion 2026-12-31 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT03958721

    Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer

    Not yet reported A Bapsi Chakravarthy, MD 20 participants Est. completion 2023-10-26 1 site
    Other conditions: Resistant Breast Cancer, Non-metastatic Invasive Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03982121

    Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris Est. completion 2020-02-12 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT03983057

    Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

    Not yet reported Zhejiang University 392 participants Est. completion 2025-11-25 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT04001621

    Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

    Not yet reported Fudan University 100 participants Est. completion 2023-12-31 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04010552

    Nalirinox Neo-pancreas RAS Mut ctDNA Study

    Not yet reported Fundación de investigación HM 20 participants Est. completion 2023-11 3 sites
    Other conditions: Resectable Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04012918

    Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study

    Not yet reported Ain Shams University 124 participants Est. completion 2021-02 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04042298

    Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy

    Kansas State University 62 participants Est. completion 2023-06-01 1 site
    Other conditions: Gastrointestinal Cancer, Head and Neck Cancer, Breast Cancer, Chemotherapy Effect, 5-Fluorouracil Toxicity
    View official trial listing →
  • Status unknown NCT NCT04097444

    CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

    Not yet reported Chugai Pharmaceutical 112 participants Est. completion 2022-08-31 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT04130854

    INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

    Not yet reported University of Texas Southwestern Medical Center 58 participants Est. completion 2026-01-30 4 sites
    Other conditions: Locally Advanced Rectal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04164615

    Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection

    Not yet reported Genor Biopharma Co., Ltd. 336 participants Est. completion 2020-11 1 site
    Other conditions: HER-2-positive Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04170530

    Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer

    Not yet reported First Affiliated Hospital of Zhejiang University 51 participants Est. completion 2022-01-01 1 site
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Completed NCT NCT04224402

    Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.

    Not yet reported Yuhong Li 80 participants Est. completion 2022-12-31 1 site
    Other conditions: Pancreatic Cancer Resectable
    View official trial listing →
  • Completed NCT NCT04229004

    A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

    Not yet reported Pancreatic Cancer Action Network 502 participants Est. completion 2025-02-05 25 sites
    Other conditions: Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04230187

    Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal Cancer

    Not yet reported Yanhong Deng 528 participants Est. completion 2029-06-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04252456

    Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status

    Not yet reported Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 150 participants Est. completion 2021-02 16 sites
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT04260269

    Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study

    Helsinki University Central Hospital 200 participants Est. completion 2027-12 13 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT04262687

    Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate

    Not yet reported Federation Francophone de Cancerologie Digestive 55 participants Est. completion 2024-09-30 88 sites
    Obstructive sleep apnea Other conditions: Colorectal Cancer Metastatic, High Immune Infiltrate
    View official trial listing →
  • Status unknown NCT NCT04301557

    PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

    Not yet reported Sun Yat-sen University 25 participants Est. completion 2024-12-30 1 site
    Other conditions: DMMR Colorectal Cancer, MSI-H Colorectal Cancer, Locally Advanced Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04307147

    NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy

    Not yet reported Fudan University 316 participants Est. completion 2021-09-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04309578

    A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

    Not yet reported Asan Medical Center 28 participants Est. completion 2024-12-13 1 site
    Other conditions: Gastric or Gastroesophageal Junction(GEJ) Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04393584

    FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

    Not yet reported, Not yet reported Blokhin's Russian Cancer Research Center 538 participants Est. completion 2026-01-01 1 site
    Other conditions: Stomach Neoplasms, Gastrointestinal Neoplasms, Docetaxel, Oxaliplatin, Fluoruracil, Irinotecan Hydrochloride
    View official trial listing →
  • Status unknown NCT NCT04401709

    Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer

    Not yet reported Samsung Medical Center 490 participants Est. completion 2025-03-30 1 site
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT04510064

    Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial

    Not yet reported Fudan University 40 participants Est. completion 2024-07-31 1 site
    Other conditions: Metastatic Gastric Cancer, Locally Advanced Gastric Adenocarcinoma, Gastric Cancer Adenocarcinoma Metastatic
    View official trial listing →
  • Completed NCT NCT04513951

    AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients

    Not yet reported Gruppo Oncologico del Nord-Ovest 62 participants Est. completion 2024-12-31 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT04554836

    MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab

    Not yet reported TheraOp 6 participants Est. completion 2024-06-11 4 sites Stand-alone
    Other conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
    View official trial listing →
  • Active, not recruiting NCT NCT04556773

    A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

    Not yet reported AstraZeneca 138 participants Est. completion 2027-06-01 37 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04571489

    A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

    Not yet reported Lee's Pharmaceutical Limited 60 participants Est. completion 2023-12-01 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04595565

    Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

    Not yet reported GBG Forschungs GmbH 1332 participants Est. completion 2029-03-30 163 sites
    Other conditions: HER2-negative Breast Cancer, Triple Negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04611724

    A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer

    Not yet reported Asan Medical Center 35 participants Est. completion 2024-09-30 1 site
    Other conditions: Urachal Cancer
    View official trial listing →
  • Withdrawn NCT NCT04682249

    Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC

    Not yet reported Sun Yat-sen University Est. completion 2021-02-01 1 site Stand-alone
    Other conditions: ICC
    View official trial listing →
  • Status unknown NCT NCT04699994

    Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel

    Not yet reported Keio University 60 participants Est. completion 2024-10-31 1 site
    Other conditions: Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04747951

    Total Neoadjuvant Therapy in Rectal Cancer Treatment

    Not yet reported State Scientific Centre of Coloproctology, Russian Federation 280 participants Est. completion 2023-11-01 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT04761614

    Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported Ning Jin 13 participants Est. completion 2023-05-06 1 site Stand-alone
    Other conditions: Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT04786210

    Treatment of Keloids With Fractional Erbium Laser-Assisted 5-Fluorouracil Versus Laser-Assisted Corticosteroid

    Not yet reported NYU Langone Health 20 participants Est. completion 2022-12-16 1 site Stand-alone
    Other conditions: Keloid Scar
    View official trial listing →
  • Status unknown NCT NCT04835064

    Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

    Not yet reported Fudan University 600 participants Est. completion 2024-12-01
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Withdrawn NCT NCT04859582

    Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension

    Not yet reported Merck Sharp & Dohme LLC Est. completion 2024-11-29 28 sites Stand-alone
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Status unknown NCT NCT04913662

    Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis

    Not yet reported Seoul National University Bundang Hospital 18 participants Est. completion 2022-06-30 1 site
    Other conditions: Stomach Neoplasm, Peritoneal Metastases
    View official trial listing →
  • Status unknown NCT NCT04932187

    Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3)

    Not yet reported Ruijin Hospital 20 participants Est. completion 2025-07-01 1 site
    Other conditions: Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi)
    View official trial listing →
  • Status unknown NCT NCT04994236

    Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

    Not yet reported Hui-Chuan Sun 49 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05022030

    First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes

    Not yet reported West China Hospital 150 participants Est. completion 2026-06-01 1 site
    Other conditions: Colo-rectal Cancer, Capecitabine, Cetuximab
    View official trial listing →
  • Status unknown NCT NCT05042791

    A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

    Not yet reported Jiangxi Provincial Cancer Hospital 362 participants Est. completion 2025-09-30 1 site
    Other conditions: HER2-positive Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05057663

    Intralesional Treatment of Plantar Wart

    Not yet reported Sohag University 40 participants Est. completion 2022-09-01 1 site
    Other conditions: Plantar Wart
    View official trial listing →
  • Status unknown NCT NCT05074966

    The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

    Not yet reported Chinese Academy of Medical Sciences 314 participants Est. completion 2025-06-24 1 site
    Other conditions: Colo-rectal Cancer
    View official trial listing →
  • Completed NCT NCT05116891

    A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors

    Not yet reported, Not yet reported Cantargia AB 40 participants Est. completion 2023-06-23 6 sites
    Other conditions: Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer, Biliary Tract Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05141721

    A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Seattle Project Corporation 700 participants Est. completion 2027-03 43 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT05198609

    Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

    Not yet reported Sun Yat-sen University 214 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05207735

    PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.

    Not yet reported Henan Cancer Hospital 73 participants Est. completion 2024-12
    Other conditions: Cholangiocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT05249101

    A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma

    Not yet reported, Not yet reported CG Pharmaceuticals, Inc 70 participants Est. completion 2026-07 16 sites
    Other conditions: Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT05268510

    Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma

    Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 31 participants Est. completion 2025-01-09 1 site
    Other conditions: Esophagogastric Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05290116

    HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma

    Not yet reported Yunfei Yuan 17 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05315830

    A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric

    Not yet reported The First Affiliated Hospital of Bengbu Medical University 10 participants Est. completion 2024-03-01 1 site Stand-alone
    Other conditions: Adenocarcinoma - GEJ, Adenocarcinoma of the Stomach
    View official trial listing →
  • Active, not recruiting NCT NCT05374512

    A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

    Not yet reported AstraZeneca 644 participants Est. completion 2026-12-31 228 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05413811

    Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

    Not yet reported UNC Lineberger Comprehensive Cancer Center 180 participants Est. completion 2025-06-30 1 site Stand-alone
    Other conditions: Cervical Cancer, CIN2, CIN3, Human Immunodeficiency Virus, Human Papillomavirus
    View official trial listing →
  • Terminated NCT NCT05417386

    FOLFIRINOX + NIS793 in Pancreatic Cancer

    Not yet reported Colin D. Weekes, M.D., PhD 4 participants Est. completion 2023-07-10 1 site Stand-alone
    Other conditions: Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05493332

    HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 93 participants Est. completion 2024-09 Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05494320

    the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

    Ain Shams University 120 participants Est. completion 2022-12-31 1 site
    Other conditions: Gastrointestinal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05502393

    A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors

    Not yet reported Shanghai Junshi Bioscience Co., Ltd. 133 participants Est. completion 2027-12-31 20 sites
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT05529355

    Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

    Not yet reported Anhui Chest Hospital 45 participants Est. completion 2023-09-18
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT05568095

    A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

    Not yet reported Arcus Biosciences, Inc. 1040 participants Est. completion 2026-08-28 168 sites Stand-alone
    Other conditions: Advanced Upper Gastrointestinal Tract Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05580887

    Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

    Moscow Clinical Scientific Center 35 participants Est. completion 2025-08 1 site
    Other conditions: Breast Cancer, Pancreas Cancer
    View official trial listing →
  • Completed NCT NCT05607186

    Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute

    Singapore General Hospital 59 participants Est. completion 2019-12-31
    Other conditions: Rectal Cancer, Oncology
    View official trial listing →
  • Active, not recruiting NCT NCT05621499

    HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 60 participants Est. completion 2026-12 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT05680870

    The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

    Not yet reported Aya Mohamed Sadek Elsaid 46 participants Est. completion 2024-12-12 1 site
    Other conditions: Chemotherapy Induced Peripheral Neuropathy
    View official trial listing →
  • Active, not recruiting NCT NCT05715931

    Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

    Not yet reported Yu jiren 30 participants Est. completion 2028-10-01 8 sites
    Other conditions: Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT05872841

    H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 38 participants Est. completion 2025-06-30 Stand-alone
    Other conditions: Primary Hepatocellular Carcinoma, Portal Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT05908838

    Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer

    Not yet reported ShuGuang Hospital 146 participants Est. completion 2022-12-02
    Other conditions: Gastric Cancer (Diagnosis)
    View official trial listing →
  • Status unknown NCT NCT05948072

    Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

    Not yet reported Fudan University 250 participants Est. completion 2026-07-15 1 site
    Other conditions: Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Status unknown NCT NCT05964543

    The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

    Not yet reported, Not yet reported QureBio Ltd. 72 participants Est. completion 2025-08-30 1 site
    Other conditions: Gastroesophageal Junction (GEJ) Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05974059

    Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 20 participants Est. completion 2024-08-01 1 site
    Other conditions: Locally Advanced Unresectable Gastric Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT05976048

    Implementation of Actinic Keratosis Guideline Among General Practitioners.

    Maastricht University Medical Center 1000 participants Est. completion 2025-12 1 site
    Other conditions: Actinic Keratoses
    View official trial listing →
  • Status unknown NCT NCT05986227

    The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):

    Not yet reported, Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 126 participants Est. completion 2026-07-01
    Other conditions: Gastroesophageal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT06041035

    A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 115 participants Est. completion 2025-10 1 site
    Other conditions: Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT06123455

    Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer

    Not yet reported Tang-Du Hospital 60 participants Est. completion 2025-07-31 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT06139211

    A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

    Not yet reported, Not yet reported Shanghai Junshi Bioscience Co., Ltd. 66 participants Est. completion 2026-05-28 1 site Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT06150144

    The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

    Not yet reported University of Aleppo 40 participants Est. completion 2025-05-25 1 site Stand-alone
    Other conditions: Basal Cell Carcinoma, BCC
    View official trial listing →
  • Status unknown NCT NCT06154590

    Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

    DR. DIANE CHISESI NFS. MD. PHD. 100 participants Est. completion 2026-09 1 site
    Other conditions: Metastatic Breast Cancer, Tumor, Muscle Neoplasms, Chronic Pain
    View official trial listing →
  • Completed NCT NCT06175676

    Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis

    Not yet reported Tianjin Medical University Eye Hospital 90 participants Est. completion 2023-12-03 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Dacryocystorhinostomy, Fluorouracil, Chronic Dacryocystitis
    View official trial listing →
  • Status unknown NCT NCT06198465

    Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma

    Not yet reported Xijing Hospital 24 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: Adebrelimab, Esophageal Cancer, Perioperative Period
    View official trial listing →
  • Completed NCT NCT06199297

    Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

    Sun Yat-sen University 188 participants Est. completion 2023-07-25 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06259721

    Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

    Not yet reported Jiangxi Provincial Cancer Hospital 22 participants Est. completion 2026-08-09 1 site
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06329947

    A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD

    Not yet reported Rui-hua Xu, MD, PhD 37 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Advanced Pancreatic Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06375317

    HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure

    Not yet reported Yehua Shen 42 participants Est. completion 2026-10-30 Stand-alone
    Other conditions: HCC - Hepatocellular Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06382142

    A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)

    Not yet reported Sichuan Baili Pharmaceutical Co., Ltd. 418 participants Est. completion 2027-12 1 site
    Other conditions: Triple-Negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06401447

    TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma

    Not yet reported Fudan University 50 participants Est. completion 2027-07-10 1 site
    Other conditions: Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06463444

    Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models

    Not yet reported Chen Xiaoping 30 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: HCC, Precision Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT06483386

    Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 109 participants Est. completion 2026-12-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06561763

    TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma

    Not yet reported Sun Yat-sen University 416 participants Est. completion 2031-08-20
    Other conditions: High Risk Locally Advanced Nasopharyngeal Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06766019

    Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 47 participants Est. completion 2027-09-30 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06952621

    Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

    Not yet reported Tang-Du Hospital 390 participants Est. completion 2028-12-28 1 site
    Other conditions: Esophageal Squamous Cell Carcinoma (ESCC)
    View official trial listing →
  • Not yet recruiting NCT NCT06959693

    A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

    Not yet reported, Not yet reported Sun Yat-sen University 590 participants Est. completion 2030-06-30 1 site
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Active, not recruiting NCT NCT06967155

    A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer

    Not yet reported Blokhin's Russian Cancer Research Center 23 participants Est. completion 2028-06-10 1 site
    Other conditions: Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT06975917

    Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)

    Ankara University 600 participants Est. completion 2025-05-30 1 site
    Other conditions: Biliary Tract Cancer, Biliary Tract Cancers (BTC)
    View official trial listing →
  • Not yet recruiting NCT NCT06993025

    Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2027-04-25 2 sites
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07026123

    A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China

    RenJi Hospital 40 participants Est. completion 2027-07-31 1 site
    Other conditions: Advanced Pancreatic Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07074353

    Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

    Not yet reported Zhejiang Cancer Hospital 360 participants Est. completion 2030-07-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07132008

    Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

    Not yet reported First Affiliated Hospital of Guangxi Medical University 94 participants Est. completion 2030-09-30 1 site
    Other conditions: Colonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint Inhibitors
    View official trial listing →
  • Not yet recruiting NCT NCT07161453

    Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative Pathology

    Not yet reported Liaoning Cancer Hospital & Institute 500 participants Est. completion 2027-12-31
    Other conditions: Gastric / Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07277842

    PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

    Not yet reported Sun Yat-sen University 382 participants Est. completion 2028-12-29 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Locally Advanced Low Rectal Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07384377

    JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan

    Not yet reported Shanghai JMT-Bio Inc. 123 participants Est. completion 2028-06-15
    Other conditions: HER2-positive Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT07391163

    Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer

    Not yet reported Tanta University 46 participants Est. completion 2026-01-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07449780

    A Study of AK104 (SC) in Combination With Oxaliplatin and Capecitabine (XELOX) Versus AK104 (IV) in Combination With XELOX in Participants With Unresectable Locally Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

    Not yet reported Akeso 422 participants Est. completion 2028-02-15
    Other conditions: Gastric / Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07486687

    Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

    Not yet reported The Netherlands Cancer Institute 1000 participants Est. completion 2036-04
    Other conditions: Triple Negative Breast Cancer (TNBC), Early Setting, Early Stage Triple-Negative Breast Carcinoma, Triple -Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III
    View official trial listing →
  • Not yet recruiting NCT NCT07503639

    Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

    Not yet reported Fudan University 134 participants Est. completion 2030-04
    Other conditions: Locally Advanced Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07515963

    FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

    Not yet reported Zhongnan Hospital 24 participants Est. completion 2028-02-01 1 site
    Other conditions: Colo-rectal Cancer
    View official trial listing →
  • Completed NCT NCT07529613

    Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma

    Not yet reported, Not yet reported National Cancer Center Hospital East 30 participants Est. completion 2025-12-31 1 site
    Other conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07549906

    Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

    Not yet reported Sun Yat-sen University 45 participants Est. completion 2026-12-31
    Other conditions: Colon Cancer (Stage II &Amp; III), Immunotherapy, Beta Blocker, Neoadjuvant Chemoimmunotherapy
    View official trial listing →
  • Not yet recruiting NCT NCT07585279

    A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Hebei Medical University Fourth Hospital 408 participants Est. completion 2032-02-28 1 site
    Other conditions: Metastatic Colorectal Cancer (CRC), Liposomal Irinotecan, Second-Line
    View official trial listing →
  • Not yet recruiting NCT NCT07621497

    FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

    Not yet reported Sun Yat-sen University 229 participants Est. completion 2030-06-01 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Not yet recruiting NCT NCT07680569

    Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma

    Not yet reported, Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 40 participants Est. completion 2027-12 Stand-alone
    Other conditions: GC/GEJC
    View official trial listing →
  • Not yet recruiting NCT NCT07750041

    A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal Cancer

    Not yet reported, Not yet reported CSPC Megalith Biopharmaceutical Co.,Ltd. 260 participants Est. completion 2029-08-30 1 site Stand-alone
    Other conditions: Unresectable Advanced or Metastatic Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07848568

    Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma

    Not yet reported, Not yet reported Children's Oncology Group 70 participants Est. completion 2037-06-30 Stand-alone
    Other conditions: Childhood Posterior Fossa Ependymoma
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluracil, AccuSite, Carac, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.